Is Systemic Immune-Inflammation Index a Real Non-Invasive Biomarker to Predict Oncological Outcomes in Patients Eligible for Radical Cystectomy?

MLA

Russo, Pierluigi, et al. “Is Systemic Immune-Inflammation Index a Real Non-Invasive Biomarker to Predict Oncological Outcomes in Patients Eligible for Radical Cystectomy?” Medicina (1010660X), vol. 59, no. 12, Dec. 2023, p. 2063. EBSCOhost, https://doi.org/10.3390/medicina59122063.

APA

Russo, P., Marino, F., Rossi, F., Bizzarri, F. P., Ragonese, M., Dibitetto, F., Filomena, G. B., Marafon, D. P., Ciccarese, C., Iacovelli, R., Pandolfo, S. D., Aveta, A., Cilio, S., Napolitano, L., & Foschi, N. (2023). Is Systemic Immune-Inflammation Index a Real Non-Invasive Biomarker to Predict Oncological Outcomes in Patients Eligible for Radical Cystectomy? Medicina (1010660X), 59(12), 2063. https://doi.org/10.3390/medicina59122063

Chicago

Russo, Pierluigi, Filippo Marino, Francesco Rossi, Francesco Pio Bizzarri, Mauro Ragonese, Francesco Dibitetto, Giovanni Battista Filomena, et al. 2023. “Is Systemic Immune-Inflammation Index a Real Non-Invasive Biomarker to Predict Oncological Outcomes in Patients Eligible for Radical Cystectomy?” Medicina (1010660X) 59 (12): 2063. doi:10.3390/medicina59122063.